Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Crypto

Biotech Firms Turn to Cryptocurrencies to Boost Stock Prices Amid Funding Challenges

by Team Lumida
August 26, 2025
in Crypto
Reading Time: 3 mins read
A A
0
Bitcoin Plunges to $64K Amid U.S. Tech Stock Turmoil

"Nobody gets me Bitcoins!" by zcopley is licensed under CC BY-SA 2.0

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways

Powered by lumidawealth.com

  • At least 10 small biotech companies have pivoted to digital assets in 2025, using cryptocurrencies to revive flagging shares and attract investor interest.
  • Examples include ETHZilla (formerly 180 Life Sciences), which accumulated over $350 million in Ether tokens, and Sonnet BioTherapeutics, which surged 243% on plans to become a public crypto treasury.
  • These moves often lead to short-lived stock spikes but reflect deeper struggles in biotech funding and innovation pipelines.
  • Industry experts view crypto pivots as a last-ditch effort by management to justify their existence amid stalled drug development and funding shortages.
  • The Nasdaq Biotechnology Index has fallen about 13% since 2021, while the broader S&P 500 has risen 46%, highlighting biotech’s underperformance.
  • Raising capital through traditional means has become harder, with IPOs and fund inflows declining significantly in the sector.
  • Crypto investments carry risks, including stock price volatility tied to crypto market swings and potential alienation of core biotech investors.
  • Some companies, like Riot Platforms, have seen sustained gains after pivoting to crypto, but overall success remains limited.

What’s Happening?

Struggling biotech firms are increasingly turning to cryptocurrencies as a strategy to boost stock prices and attract capital amid a challenging funding environment and stalled drug pipelines. This trend reflects broader sector difficulties and investor skepticism.

Why Does It Matter?

The crypto pivot highlights the financial pressures biotech companies face and raises questions about the sustainability of such strategies. It also signals potential volatility for investors and the need for clearer paths to innovation and growth in biotech.

What’s Next?

Investors will watch how these crypto-biotech hybrids perform and whether the trend continues or fades. The sector’s recovery depends on renewed drug development success and improved funding conditions.

Source
Previous Post

Trump Says U.S. Holds Greater Leverage Over China on Rare Earth Magnets Amid Trade Talks

Next Post

Trump Calls for European Troops in Ukraine; Public and Political Support Across Europe Is Tepid

Recommended For You

VanEck Drops Gemini as Custodian of Its Bitcoin, Ether and Solana ETFs, Leaving Coinbase Custody in Place From About Feb. 16, 2027

by Team Lumida
1 day ago
Gemini Stock Down 80% From IPO Peak; $753M Valuation Revives Takeover Speculation as Regulatory Licenses Become Acquisition Target

VanEck is ending Gemini’s custody and clearing role on its bitcoin, ether and Solana ETFs, with the change due around Feb. 16, 2027, CoinDesk reported.

Read more

Bitcoin Breaks $60,000 in the U.S. Session and Later Friday Sinks Below $57,000, Its Lowest Since September 2024

by Team Lumida
1 day ago

Bitcoin fell below $60,000 in U.S. hours and later Friday sank below $57,000, its lowest since September 2024, as crypto liquidations hit $2.4 billion.

Read more

Hyperscale Data, Which Sold Its Last 211 Bitcoin, Warns of ‘Substantial Doubt’ as It Needs $74.8 Million More to Finish Its Michigan AI Data Center With $17 Million in Cash

by Team Lumida
3 days ago

Former bitcoin miner Hyperscale Data warned it may not fund the rest of its Michigan AI data center after selling all its bitcoin.

Read more

Bitcoin Erases Its Bessent Rally Near $64,000 as Perpetual Futures Open Interest Falls to $41.6 Billion, the Lowest Since November 2024, and Citi Cuts Its Targets

by Team Lumida
3 days ago

Bitcoin wiped out its late-summer rally as leverage and liquidity faded, ETF outflows hit $2.6 billion this month, and Citi trimmed its BTC and ETH targets.

Read more

MARA Prices $185 Million of 8.75% Debt to Help Fund Its $1.5 Billion Ohio Power Plant Deal, a Week After Selling $1.1 Billion of Bitcoin to Repay Loans

by Team Lumida
3 days ago

MARA priced $185 million of 8.75% bonds tied to its Long Ridge power plant purchase, and its shares rose about 4.7% premarket.

Read more

US Judge Clears MIT-Educated Brothers of $25 Million Ethereum Fraud, Ruling the Network Has “No Terms of Use” in the Government’s First Criminal MEV Case

by Team Lumida
4 days ago

A federal judge acquitted Anton and James Peraire-Bueno of wire fraud over a $25 million Ethereum MEV trade, closing the first US criminal MEV case.

Read more

Anthropic Crypto Futures Imply a $1.7 Trillion Valuation Even After a 21% Slide, 24% Above the Top of the $78 IPO Range, With $422 Million of Open Interest Two Days Before the Debut

by Team Lumida
4 days ago

Anthropic perpetual futures have fallen as much as 21% to about $97 but still imply roughly $1.7 trillion, above the $1.4 trillion IPO-range ceiling.

Read more

Ripple-Backed Evernorth Has Written Down Its Pre-Listing XRP by $505 Million, Nearly 60% of Its $847 Million Cost, in Its First Quarterly Report

by Team Lumida
5 days ago

Nasdaq-listed Evernorth carries its 346 million XRP at $342 million after $505 million of impairments, below the tokens’ Sept. 30 market value.

Read more

Former Robinhood Engineer Pleads Guilty to Trading Hyperliquid Perpetuals Ahead of Crypto Listings, Forfeiting $125,523 in Profits

by Team Lumida
5 days ago

Ex-Robinhood engineer Huaisong Xiang pleaded guilty to wire fraud for trading Hyperliquid perpetual futures ahead of Robinhood’s crypto listing announcements.

Read more

Wells Fargo’s Reported IBIT Stake Doubles to 49.58 Million Shares Worth $2.35 Billion, Exposure to About 28,070 Bitcoin, Nearly Matching Tesla and SpaceX Combined

by Team Lumida
5 days ago

Wells Fargo reported 49.58 million IBIT shares worth $2.35 billion at Sept. 30, making it the largest reported IBIT holder among investment managers.

Read more
Next Post
Trump Tariffs Leave Key Questions on China Supply Chain Rules Unanswered

Trump Calls for European Troops in Ukraine; Public and Political Support Across Europe Is Tepid

Microsoft’s Blue Screen of Death: What You Need to Know

Microsoft Probes Employee Occupation of Brad Smith’s Office Over Israel–Gaza Concerns

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

China’s Financial Overhaul: Xi’s Strategy to Rebalance $9.1 Trillion Debt Crisis

China’s AI Is Closing In on America’s Best — and Winning on Price, Adoption, and Open-Source Strategy

August 20, 2026
Will September’s Fed Rate Cuts Surprise Investors? Here’s What Deutsche Bank Predicts

Fed Divisions Thrust Powell Into Uncharted Territory

September 17, 2025
Luxury Brands Face Fallout from Pandemic Price Hikes as Sales Decline

Luxury Brands Face Fallout from Pandemic Price Hikes as Sales Decline

May 28, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Legacy
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Investing Philosophy
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Investing Philosophy
  • Latest
  • Legacy
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bank of America China Commercial Real Estate CPI data centers Donald Trump EARNINGS ELON MUSK Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Novo Nordisk Nuclear Energy Nvidia oil OpenAI private equity S&P 500 SEC Semiconductor stock market stock surge Tech Stocks tesla Trump Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018